A nationwide cohort study on diabetes severity and risk of Parkinson disease
Open accessAbstract
There is growing evidence that patients with type 2 diabetes mellitus (DM) have an increased risk of developing Parkinson’s disease (PD) and share similar dysregulated pathways. We aimed to determine whether the risk of PD increases as diabetes progresses among patients with type 2 DM. Using a nationally representative database from the Korean National Health Insurance System, 2,362,072 individuals (≥40 years of age) with type 2 DM who underwent regular health checkups during 2009–2012 were followed up until the end of 2018. The diabetes severity score parameters included the number of oral hypoglycemic agents, diabetes duration, insulin use, or presence of chronic kidney disease, diabetic retinopathy, or cardiovascular disease. Each of these characteristics was scored as one unit of diabetes severity and their sum was defined as a diabetes severity score from 0–6. We identified 17,046 incident PD cases during the follow-up. Each component of the diabetes severity score showed a similar intensity for the risk of PD. Compared with subjects with no parameters, HR values (95% confidence intervals) of PD were 1.09 (1.04–1.15) in subjects with one diabetes severity score parameter, 1.28 (1.22–1.35) in subjects with two parameters, 1.55 (1.46–1.65) in subjects with three parameters, 1.96 (1.82–2.11) in subjects with four parameters, 2.08 (1.83–2.36) in subjects with five parameters, and 2.78 (2.05–3.79) in subjects with six parameters. Diabetes severity was associated with an increased risk of developing PD. Severe diabetes may be a risk factor for the development of PD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Diabetes is a well-established risk factor for PD and is linked to faster disease progression.
“Diabetes is a well-established risk factor for PD, and has been linked to a faster disease progression”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [612]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830 · see citing works
Young, B. A., Lin, E. H. B., Korff, M. V., Simon, G., Ciechanowski, P. S., Ludman, E. J., Everson‐Stewart, S., Kinder, L. S., Oliver, M. M., Boyko, E. J., et al. (2008) · PubMed · Cited by 606 · see citing works
for the ADVANCE Collaborative group, Zoungas, S., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S. B., Heller, S. R., Marre, M., Patel, A. A., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3369-7 · Cited by 498 · see citing works
Insulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D. S., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 333 · see citing works
Kim, M. K., Han, K., Park, Y., Kwon, H., Kang, G., Yoon, K., & Lee, S. (2018) · Circulation · doi:10.1161/circulationaha.118.034978 · Cited by 267 · see citing works
Self-citationIndividualized Metabolic Surgery Score
Aminian, A., Brethauer, S. A., Andalib, A., Nowacki, A. S., Jiménez, A., Corcelles, R., Hanipah, Z. N., Punchai, S., Bhatt, D. L., Kashyap, S. R., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002407 · Cited by 257 · see citing works
Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study
De Pablo-Fernandez, E., Goldacre, R., Pakpoor, J., Noyce, A. J., & Warner, T. T. (2018) · Neurology · doi:10.1212/wnl.0000000000005771 · Cited by 242 · see citing works
Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes
Brauer, R., Wei, L., Ma, T., Athauda, D., Girges, C., Vijiaratnam, N., Auld, G., Whittlesea, C., Wong, I., & Foltynie, T. (2020) · Brain · doi:10.1093/brain/awaa262 · Cited by 233 · see citing works
Diabetes and the Risk of Developing Parkinson’s Disease in Denmark
Schernhammer, E. S., Hansen, J., Rugbjerg, K., Wermuth, L., & Ritz, B. R. (2011) · Diabetes Care · doi:10.2337/dc10-1333 · Cited by 198 · see citing works
Current Trends of Big Data Research Using the Korean National Health Information Database
Kim, M. K., Han, K., & Lee, S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0193 · Cited by 170 · see citing works
Self-citationMetabolic syndrome and risk of Parkinson disease: A nationwide cohort study
Nam, G. E., Kim, S. M., Han, K., Kim, N. H., Chung, H. S., Kim, J. W., Han, B., Cho, S.-J., Yu, J. H., Park, Y. G., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002640 · Cited by 148 · see citing works
Self-citationThe Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial
Leslie, W. S., Ford, I., Sattar, N., Hollingsworth, K. G., Adamson, A., Sniehotta, F. F., McCombie, L., Brosnahan, N., Ross, H., Mathers, J. C., et al. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0406-2 · Cited by 132 · see citing works
Understanding the Links Between Cardiovascular Disease and Parkinson's Disease
Potashkin, J., Huang, X., Becker, C., Chen, H., Foltynie, T., & Marras, C. (2019) · Movement Disorders · doi:10.1002/mds.27836 · Cited by 117 · see citing works
Rhee, S. Y., Han, K.-D., Kwon, H., Park, S.-E., Park, Y.-G., Kim, Y.-H., Yoo, S.-J., Rhee, E.-J., & Lee, W.-Y. (2020) · Diabetes Care · doi:10.2337/dc19-0760 · Cited by 109 · see citing works
Self-citationRisk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study
Won, J. H., Byun, S. J., Oh, B., Park, S. J., & Seo, H. G. (2021) · Scientific Reports · doi:10.1038/s41598-021-86011-w · Cited by 82 · see citing works
Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus
Yu, J. S., Lee, S.-H., & Kim, M. K. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.105 · Cited by 70 · see citing works
Self-citationChronic renal dysfunction, proteinuria, and risk of Parkinson's disease in the elderly
Nam, G. E., Kim, N. H., Han, K., Choi, K. M., Chung, H. S., Kim, J. W., Han, B., Cho, S.-J., Jung, S. J., Yu, J. H., et al. (2019) · Movement Disorders · doi:10.1002/mds.27704 · Cited by 65 · see citing works
Self-citationAssociation between Parkinson's disease and diabetes: Data from NEDICES study
Pablo‐Fernández, E. D., Hidalgo, F. S., Benito‐León, J., & Bermejo‐Pareja, F. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12793 · Cited by 63 · see citing works
Linking chronic kidney disease and Parkinson’s disease: a literature review
Meléndez-Flores, J. D., & Estrada-Bellmann, I. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00623-1 · Cited by 44 · see citing works
Fang, F., Zhan, Y., Zhuo, Y., Yin, D., Li, K., & Wang, Y. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12646 · Cited by 40 · see citing works
Euglycemia Indicates Favorable Motor Outcome in Parkinson's Disease
Markaki, I., Ntetsika, T., Sorjonen, K., Svenningsson, P., & for the BioPark Study Group (2021) · Movement Disorders · doi:10.1002/mds.28545 · Cited by 40 · see citing works
Cardiovascular risk factors and Parkinson's disease in 500,000 Chinese adults
Kizza, J., Lewington, S., Mappin‐Kasirer, B., Turnbull, I. J., Yu, C., Bian, Z., Chen, Y., Yang, L., Chen, Z., Clarke, R., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.732 · Cited by 37 · see citing works
Increased risks of parkinsonism in the 3 years after chronic renal failure
Lin, H., Lin, H.-C., & Chen, Y.-H. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02896.x · Cited by 33 · see citing works
Yoo, H., Choo, E., & Lee, S. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00605-5 · Cited by 33 · see citing works
Self-citationGini, R., Schuemie, M. J., Mazzaglia, G., Lapi, F., Francesconi, P., Pasqua, A., Bianchini, E., Montalbano, C., Roberto, G., Barletta, V., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012413 · Cited by 31 · see citing works
Lee, S. E., Han, K., Baek, J. Y., Ko, K. S., Lee, K., & Koh, E. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02774 · Cited by 31 · see citing works
Self-citationZghebi, S. S., Mamas, M. A., Ashcroft, D. M., Salisbury, C., Mallen, C. D., Chew-Graham, C. A., Reeves, D., van Marwijk, H., Qureshi, N., Weng, S. F., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000962 · Cited by 23 · see citing works
Mori, T., Nagata, T., Nagata, M., Fujimoto, K., Fujino, Y., & Mori, K. (2021) · BMC Public Health · doi:10.1186/s12889-021-11913-3 · Cited by 21 · see citing works
Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes
Lee, S., Han, K., Kwon, H., & Kim, M. K. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1218 · Cited by 20 · see citing works
Self-citationAssessing the severity of Type 2 diabetes using clinical data‐based measures: a systematic review
Zghebi, S. S., Panagioti, M., Rutter, M. K., Ashcroft, D. M., van Marwijk, H., Salisbury, C., Chew-Graham, C. A., Buchan, I. E., Qureshi, N., Peek, N. B., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.13905 · Cited by 19 · see citing works
Park, S. H., Nam, G. E., Han, K., Huh, Y., Kim, W., Lee, M., Koh, E.-S., Kim, E. S., Kim, M. K., Kwon, H., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212589 · Cited by 13 · see citing works
Self-citationKoo, B. K., Park, S. H., Han, K., & Moon, M. K. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1197 · Cited by 12 · see citing works
Self-citationDowngrading of Type 2 Diabetes Mellitus (T2DM) after Obesity Surgery: Duration and Severity Matter
Runkel, M., Müller, S., Brydniak, R., & Runkel, N. S. F. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1419-3 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 74 · see citing works
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., et al. (2023) · Nutrients · doi:10.3390/nu15163585 · Cited by 63 · see citing works
Asimakidou, E., Saipuljumri, E. N., Lo, C. H., & Zeng, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01770 · Cited by 60 · see citing works
Martinez, A., Sánchez-Martínez, Á., Pickering, J. T., Twyning, M. J., Terriente-Félix, A., Chen, P., Chen, C., & Whitworth, A. J. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00701-3 · Cited by 52 · see citing works
Lisco, G., Tullio, A. D., Iovino, M., Disoteo, O., Guastamacchia, E., Giagulli, V. A., & Triggiani, V. (2023) · Biomedicines · doi:10.3390/biomedicines11112993 · Cited by 44 · see citing works
Tang, H., Lu, Y., Okun, M. S., Donahoo, W. T., Ramirez‐Zamora, A., Wang, F., Huang, Y., Armstrong, M. J., Svensson, M., Virnig, B. A., et al. (2024) · Movement Disorders · doi:10.1002/mds.29992 · Cited by 44 · see citing works
Parkinson’s Disease and Photobiomodulation: Potential for Treatment
Bicknell, B. T., Liebert, A. D., & Herkes, G. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010112 · Cited by 37 · see citing works
Pérez-Segura, I., Santiago-Balmaseda, A., Rodríguez-Hernández, L. D., Morales-Martínez, A., Martínez-Becerril, H. A., Martínez-Gómez, P. A., Delgado-Minjares, K. M., Salinas‐Lara, C., Martínez-Dávila, I. A., Guerra‐Crespo, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043264 · Cited by 29 · see citing works
The promise of GLP-1 receptor agonists for neurodegenerative diseases
Athauda, D. S., Greig, N. H., Meissner, W. G., Foltynie, T., & Gandhi, S. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194745 · Cited by 30 · see citing works
Tang, H.-L., Donahoo, W. T., Svensson, M., Shaaban, C., Smith, G. E., Jaffee, M., Huang, Y., Hu, X., Lu, Y., Salloum, R., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14048 · Cited by 22 · see citing works
Kopp, K. O., Li, Y., Glotfelty, E. J., Tweedie, D., & Greig, N. H. (2024) · Biomolecules · doi:10.3390/biom14070872 · Cited by 24 · see citing works
Aerobic exercise-induced changes in fluid biomarkers in Parkinson’s disease
Luthra, N., Mehta, N., Munoz, M. J., Fantuzzi, G., Lamotte, G. J., Haus, J. M., McFarland, N. R., Tansey, M. G., González-Latapí, P., Caraveo, G., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01042-8 · Cited by 20 · see citing works
Rahmawati, N. D., Andriani, H., Wirawan, F., Farsia, L., Waits, A., & Taufiqurahman, K. A. K. (2024) · BMC Nutrition · doi:10.1186/s40795-024-00856-8 · Cited by 20 · see citing works
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Vear, A., Heneka, M. T., & Clemmensen, C. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01263-4 · Cited by 21 · see citing works
Exploring Risk and Protective Factors in Parkinson’s Disease
Beheshti, I. (2025) · Cells · doi:10.3390/cells14100710 · Cited by 18 · see citing works
Bantounou, M. A., Shoaib, K., Mazzoleni, A., Modalavalasa, H., Kumar, N. S., & Philip, S. (2024) · Brain Disorders · doi:10.1016/j.dscb.2024.100158 · Cited by 18 · see citing works
Diabetes severity and the risk of depression: A nationwide population-based study
Cho, Y., Kim, B., Kwon, H., Han, K., & Kim, M. K. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.181 · Cited by 16 · see citing works
Self-citationMetabolic Dysfunction in Parkinson’s Disease: Unraveling the Glucose–Lipid Connection
Sian‐Hülsmann, J., Riederer, P. F., & Michel, T. M. (2024) · Biomedicines · doi:10.3390/biomedicines12122841 · Cited by 16 · see citing works
Baldensperger, T., Preissler, M., & Becker, C. F. W. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00221k · Cited by 16 · see citing works
Sohail, M. U., Batool, R. M., Aamir, J., Saad, M., Aisha, E., Jain, H., Arshad, M. S., & Ahmed, R. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112239 · Cited by 12 · see citing works
Challenges in studying air pollution to neurodegenerative diseases
Kwon, D., Paul, K., O'Sharkey, K., Paik, S. A., Yu, Y., Bronstein, J. M., & Ritz, B. R. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121597 · Cited by 10 · see citing works
The Severity of Diabetes and the Risk of Diabetic Foot Amputation: A National Cohort Study
Yu, J. S., Kim, J.-H., Kim, B., Han, K., Lee, S.-H., & Kim, M. K. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2266 · Cited by 10 · see citing works
Self-citationAssociation of triglyceride-glucose index and diabesity: evidence from a national longitudinal study
Zhang, F., Sun, Y., Bai, Y., Wu, R., & Yang, H. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02403-7 · Cited by 9 · see citing works
Faecal microbiota transplant for Parkinson’s disease: promises and future directions
Tan, E. K., Wang, J. D. J., Pettersson, S., Wang, Q., Takahashi, R., Poewe, W. H., Jankovic, J. J., & Rascol, O. (2025) · Brain · doi:10.1093/brain/awaf419 · Cited by 10 · see citing works
Kim, M. K., Han, K., Kwon, H., & Yoo, S. J. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1737 · Cited by 9 · see citing works
Self-citationXu, X., Zhang, C., Tang, G., Wang, N., & Feng, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1328979 · Cited by 9 · see citing works
GAN-Based Novel Approach for Generating Synthetic Medical Tabular Data
Nasimov, R., Nasimova, N., Mirzakhalilov, S., Tokdemir, G., Rizwan, M., Abdusalomov, A. B., & Cho, Y. I. (2024) · Bioengineering · doi:10.3390/bioengineering11121288 · Cited by 8 · see citing works
Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale
Shafieinouri, M., Hong, S., Lee, P. S., Grant, S. M., Khani, M., Dadu, A., Schuh, A. F. S., Makarious, M. B., Sandon, R., Simmonds, E., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu2937 · Cited by 7 · see citing works
White, A. C., Krout, I. N., Mouhi, S., Blackmer‐Raynolds, L., Chang, J., Kelly, S. D., Caudle, W. M., & Sampson, T. R. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf076 · Cited by 4 · see citing works
Yu, J. S., Kim, B., Han, K., & Kim, M. K. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf249 · Cited by 4 · see citing works
Self-citationKridin, K., Ofir, L., Weinstein, O., & Badarny, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1387404 · Cited by 4 · see citing works
Stinson, S. E., Shadrin, A. A., Rahman, Z., Rødevand, L. N., Broce, I., Persson, K., Selbæk, G., Stefánsson, H., Haavik, J., Parker, N., et al. (2025) · medRxiv · doi:10.1101/2025.07.31.25332114 · Cited by 4 · see citing works
Exploring ocular disorders in Parkinson's disease: A comprehensive review and future perspectives
Thacker, M., Wong, K. Y., Zhou, L., Liu, J., & Wong, M. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110225 · Cited by 3 · see citing works
Gómez‐Mayordomo, V., Jiménez‐García, R., Zamorano‐León, J. J., Carabantes-Alarcón, D., Bodas-Pinedo, A., Hernández‐Barrera, V., López‐de‐Andrés, A., & Cuadrado‐Corrales, N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134679 · Cited by 3 · see citing works
Song, J., Park, S. J., Kim, Y.-J., & Park, S. M. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1628876 · Cited by 3 · see citing works
GLP-1 agonists in neurodegeneration: a multimodal biomarker-guided approach
Santiago, J. A., Gutierrez-Silva, J. C., Hsu, W.-C., Sanchez, K., Almanza, C., Ramos, W., Haq, I. U., & Rundek, T. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.12.001 · Cited by 3 · see citing works
Diabetic cerebral microvascular disorder: from key pathologies to targeted interventions
Zhang, Q., Liu, J., & Ji, X. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2654248 · Cited by 3 · see citing works
Martinez, A., Sánchez-Martínez, Á., Pickering, J. T., Twyning, M. J., Terriente-Félix, A., Chen, P., Chen, C., & Whitworth, A. J. (2023) · Research Square · doi:10.21203/rs.3.rs-2933559/v1 · Cited by 3 · see citing works
Unraveling the molecular crossroads: T2DM and Parkinson’s disease interactions
Liu, T., KONG, X., & Wei, J. (2024) · Biocell · doi:10.32604/biocell.2024.056272 · Cited by 3 · see citing works
Avisar, H., Greenbaum, U., Djaldetti, R., & Lerner, B. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01003-1 · Cited by 2 · see citing works
Stinson, S. E., Shadrin, A. A., Rahman, Z., Rødevand, L. N., Broce, I., Selbæk, G., Stefánsson, H., Haavik, J., Parker, N., Koch, E. M., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106254 · Cited by 2 · see citing works
The Gut-Brain Axis: A Critical Link between Type 2 Diabetes and Parkinson’s disease
Almohmadi, N. H., Al‐kuraishy, H. M., Hussein, K. S., Turkistani, A., Yousef, F. M., Al-Gareeb, A. I., Abdelaziz, A. M., Elewa, Y. H. A., & Batiha, G. E. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11014-w · Cited by 2 · see citing works
Lee, M., Yu, M. H., Chae, W., Lee, Y., Lee, B. I., Kang, E. S., Cha, B., Jang, S., & Chung, M. J. (2026) · Gut · doi:10.1136/gutjnl-2025-335863 · Cited by 2 · see citing works
Chauhan, P., Pandey, P., Khan, F., & Maqsood, R. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303249690231006114308 · Cited by 2 · see citing works
Meroua, H., Achou, R., Brahim, D., Laouar, R., Razika, G., Naima, T., Abadi, N., & Satta, D. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00536-z · Cited by 1 · see citing works
Serrano‐Marín, J., Valenzuela, R., Delgado, C., Quijano, A., Navarro, G., Labandeira-García, J. L., & Franco, R. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101934 · Cited by 1 · see citing works
Moreno-López, C., Antenucci, P., Moura, J., & Bhatia, K. P. (2026) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70503 · Cited by 1 · see citing works
Kovacevic, D., Velikic, G. S., Maric, D. M., Marić, D., Puletić, M., Gvozdenović, L., Vojvodić, D., & Šupić, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073348 · Cited by 1 · see citing works
Martinez, A., Sánchez-Martínez, Á., Pickering, J. T., Twyning, M. J., Terriente-Félix, A., Chen, P., Chen, C., & Whitworth, A. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.14.540700 · Cited by 1 · see citing works
Daalen, J. M. J., Gerritsen, A., Gerritse, G., Gouman, J., Meijerink, H., Rietdijk, L. E., & Darweesh, S. K. L. (2024) · Brain Sciences · doi:10.3390/brainsci14040358
The Contribution of Mitochondrial Evolution and Dysfunction to Neurodegeneration
Wasner, K., Pereira, S. L., & Grünewald, A. (2024) · doi:10.1093/med/9780197676592.003.0004
Overview of Some Biochemical Parameters in Parkinson’s Disease
Tahiroğlu, V., & Gülçın, İ. (2024) · doi:10.69860/nobel.9786053359357.6
TPClust: Temporal Profile-Guided Subtyping Using High-Dimensional Omics DataPreprint
Hu, B., Jager, P. L. D., Bennett, D. A., Vardarajan, B. N., Wang, Y., & Lee, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.05.668514
Cui, Y., Wang, S., Zhao, W., Du, Y., Wang, L., Han, B., Zhang, M., Xu, X., Wang, S., Ma, X., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13122705
Diabetic signature on Parkinson’s disease: Insights into pathophysiology and therapeutic repurposing
Venugopal, R., Vijayaraghavan, A., Krishnan, S., Puthenveedu, D. K., Surendran, V., & Sachithanandan, S. (2026) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_64_25
Msigwa, S. S., Mkwambe, M. C., Yu, Q., Zhu, S.-G., Zhu, J., Zhang, X., & Wang, J. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2654251
Kordas, B., Matuszewski, W., Modzelewski, R., & Juranek, J. K. (2026) · Biomedicines · doi:10.3390/biomedicines14051127
Diabetes progression and its association with fracture risk in type 2 diabetes
Kim, B., Lee, K., Han, K., & Kim, M. K. (2026) · Osteoporosis International · doi:10.1007/s00198-026-08079-2
Self-citationBipolar disorder and subsequent Parkinson's disease: a meta-analysis of cohort studies
Su, L., Feng, X., Chen, Y., Tang, Z., Shi, W., Qiu, Y., & Ma, X. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1825046
A convergent metabolic-kinase signaling axis links Parkinson’s disease and multiple system atrophyPreprint
Velásquez, E., Savchenko, E., Toledo, A. G., Näsström, E., Johansson, A. I., Baldeschi, A. C., Deierborg, T., Lunnon, K., Pomeshchik, Y., Rezeli, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.11.731777
Kim, J., Yoo, B., Han, K., Jung, J.-H., Oh, S. Y., Park, K., & Youn, J. (2026) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2026.108389
Self-citationEffects of Site-Specific Glycation on α-Synuclein
Baldensperger, T., Hampel, A., & Becker, C. F. W. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00322
PAULEY, M. E., Coughlan, C. M., Dong, F., Bucca, B. C., Tanner, B., CHARTIER-LOGAN, C. J., Shapiro, A. L. B., & Snell‐Bergeon, J. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1860993
Wang, X., Zhou, S., Yang, N., & Xu, X. (2026) · Genes · doi:10.3390/genes17091004
Parkinson's disease pathogenesis: From molecular insights to novel therapies
Ramli, M. D. C., Abidin, Z. Z., Okunsai, B., Umbar, G. S. A., & Mauta, T. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27702-3.00027-3
Metabolic endotyping for mechanism-informed Alzheimer’s and Parkinson’s disease trials
Santiago, J. A., Rascol, O., Foltynie, T., Meissner, W. G., Potashkin, J. A., Gutierrez-Silva, J. C., Shahrestani, M. N., Wu, Y., Rundek, T., & Haq, I. U. (2026) · Med · doi:10.1016/j.medj.2026.101336
- Authors
- Han, K., Kim, B., Lee, S. H., & Kim, M. K.
- Affiliations
- Soongsil University (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- Corresponding author
- Kim, Mee Kyoung
- Venue
- npj Parkinson's Disease
- Published
- 2023-01-27
- Volume
- 9
- Issue
- 1
- Pages
- 11-11
- ISSN
- 2373-8057 (ISSN-L)
- PMC
- PMC9883517
- OpenAlex
- W4318219114
- Cited by
- 67
- References
- 33
- Citations by year
- 2026: 18 · 2025: 19 · 2024: 23 · 2023: 7
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- npj Parkinson s Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- Parkinson's disease, type 2 diabetes, diabetes severity, oral antidiabetic drugs, insulin use, diabetes duration, chronic kidney disease, diabetic retinopathy, cardiovascular disease, Parkinson's disease risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
